Efficacy and safety of sublingual immunotherapy using house dust mite tablet for 1-4 years old children with perennial allergic rhinitis.
Koki SasamotoKen-Ichi NagakuraTomoyuki AsaumiNaoko FusayasuKatsuyo Ohashi-DoiNoriyuki YanagidaSakura SatoMotohiro EbisawaPublished in: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (2024)
This pilot study demonstrated the efficacy, safety, and immunomodulatory effects of HDM SLIT-tablet in preschoolers with AR.